News
NICE says yes to Grifols' Tavlesse for rare blood disorder I...
Patients across the UK with chronic immune thrombocytopenia (ITP) now have another treatment option, after NICE backed use of Spanish drugmaker Grifols' Tavlesse for adults with the rare bl